RADELBI Trademark

Trademark Overview


On Thursday, September 2, 2021, a trademark application was filed for RADELBI with the United States Patent and Trademark Office. The USPTO has given the RADELBI trademark a serial number of 79321659. The federal status of this trademark filing is REGISTERED as of Tuesday, May 24, 2022. This trademark is owned by Novartis AG. The RADELBI trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
radelbi

General Information


Serial Number79321659
Word MarkRADELBI
Filing DateThursday, September 2, 2021
Status700 - REGISTERED
Status DateTuesday, May 24, 2022
Registration Number6726940
Registration DateTuesday, May 24, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2022

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 8, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCH

Trademark Events


Event DateEvent Description
Sunday, September 11, 2022NOTIFICATION PROCESSED BY IB
Friday, August 19, 2022FINAL DISPOSITION NOTICE SENT TO IB
Thursday, August 18, 2022FINAL DISPOSITION PROCESSED
Thursday, June 23, 2022GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, May 24, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, May 24, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, March 1, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022PUBLISHED FOR OPPOSITION
Sunday, February 27, 2022NOTIFICATION PROCESSED BY IB
Wednesday, February 9, 2022NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, February 9, 2022NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, February 9, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 24, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 21, 2022ASSIGNED TO EXAMINER
Monday, November 8, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 8, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 8, 2021TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 8, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 8, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 8, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, October 12, 2021APPLICATION FILING RECEIPT MAILED
Friday, October 8, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Wednesday, October 6, 2021LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, September 30, 2021SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB